MicroArray in Leukemia Diagnosis- a Validation Experiment (MALDIVE)

Conventional cytogenetic studies in myeloproliferative neoplasms (MPNs) have provided pathogenic, diagnostic and prognostic information and in certain instances guide therapeutic decisions. It is therefore reasonable to hypothesize that a higher resolution examination of chromosomes might reveal additional changes that are scientifically as well as clinically relevant.

Oligonucleotide array comparative genomic hybridization (oligo aCGH) in microarray format has been used previously only in the research setting to detect unbalanced chromosomal anomalies. It is now possible to use this technology in diagnosing hematological malignancies.

This educational program is designed for hematologists, oncologists, nurse practitioners, physician assistants and other healthcare professionals involved in diagnosing and treating hematological cancers.